Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

NCT01393509 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT01393509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
July 6, 2011
Completion date
March 23, 2023
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, metastatic solid tumor, myeloproliferative neoplasms (mpn)